Investing18d
GSK's depemokimab under review in China and Japan for asthma, CRSwNP
GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.31 billion and an impressive gross profit margin of 72.39%, has announced that its new drug ...
Investing18d
GSK's depemokimab gets EMA nod for asthma and nasal polyps
GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently undervalued according to InvestingPro Fair Value metrics, has reached a ...
Investing21d
Airbnb's SWOT analysis: stock faces growth challenges amid global expansion
Airbnb, Inc. (NASDAQ:ABNB), the leading online marketplace for short-term lodging and experiences with a market capitalization of $79.28 billion, finds itself at a crossroads as it navigates a complex ...
The Motley Fool UK24d
Anywhere under £45.27, GSK’s share price looks cheap to me
GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I’ve investigated whether this is the case. When investing, your capital is ...
Investing24d
Micron Technology's SWOT analysis: HBM growth and DRAM recovery drive stock outlook
Micron Technology, Inc. (NASDAQ:MU), a leading provider of memory and storage solutions, is navigating a complex semiconductor landscape marked by technological advancements and market fluctuations.
Bollywood Hungama25d
Akshay Kumar’s Sky Force SWOT analysis: A deep dive into Strengths, Weaknesses, Opportunities, and Threats
Sky Force, set to release on 24 January 2025, promises to be an adrenaline-fueled action-adventure that blends patriotism with spectacular aerial combat. Directed by Sandeep Kewlani and produced ...